FDA approves first new Alzheimer's drug in 20 years
FDA approves first new Alzheimer’s drug in 20 years June is Alzheimer’s and Brain Awareness Month. Alzheimer’s Disease is a form of dementia – a syndrome characterized by deterioration in memory, thinking, behavior and ability to do everyday tasks.   Dementia affects 50 million people worldwide with 10 million cases being diagnosed each year. Alzheimer’s Disease (AD) is the most common form of dementia making up
Looking ahead to 2021 ASCO Annual Meeting: Oncology
Looking ahead to 2021 ASCO Annual Meeting: Oncology The annual meeting of the American Society of Clinical Oncology (ASCO), will kick off on June 4. Featuring presentations on the latest ground-breaking science in oncology, this event is always a must-attend for anyone involved in developing better treatments for cancer. Cancer patients and COVID This year ASCO is more relevant than ever considering the effects of
Join Cromos Pharma's Vlad Bogin at OCT Eastern Europe June 15
Join Cromos Pharma’s Vlad Bogin at OCT Eastern Europe June 15 Why are Central and Eastern Europe the hottest locations for clinical trials? Join Vlad Bogin, MD, FACP, CEO Cromos Pharma at #OCTEasternEurope15 June 2021 to find out more.  At Cromos Pharma we have in-depth knowledge of these regions and the expertise to manage your clinical trial from start to end. Email bd@cromospharma.com to set up a meeting to discuss your needs.

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us